Interventions for treating oral mucositis for patients with cancer receiving treatment (Q24245357)

https://api.crossref.org/works/10.1002%2F14651858.CD001973.PUB3

Randomized clinical trial of the effectiveness of 3 commonly used mouthwashes to treat chemotherapy-induced mucositis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001973.PUB3

Radiation-induced mucositis: a randomized clinical trial of micronized sucralfate versus salt & soda mouthwashes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001973.PUB3

Randomized trial of opioids versus tricyclic antidepressants for radiation-induced mucositis pain in head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001973.PUB3

Decrease of duration and symptoms in chemotherapy-induced oral mucositis by topical GM-CSF: results of a prospective randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001973.PUB3

Self-administration of morphine in bone marrow transplant patients reduces drug requirement

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001973.PUB3

Patient-controlled analgesic administration. A comparison of steady-state morphine infusions with bolus doses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001973.PUB3

Patient-controlled analgesic infusions: alfentanil versus morphine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001973.PUB3

Adolescents use patient-controlled analgesia effectively for relief from prolonged oropharyngeal mucositis pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001973.PUB3

A double-blind, placebo-controlled, randomized trial to evaluate the role of tetrachlorodecaoxide in the management of chemotherapy-induced oral mucositis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001973.PUB3

Allopurinol mouthwashes in the treatment of 5-fluorouracil-induced stomatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001973.PUB3

Relaxation and imagery and cognitive-behavioral training reduce pain during cancer treatment: a controlled clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001973.PUB3

Mouth-washings with recombinant human granulocyte-macrophage colony stimulating factor (rhGM-CSF) do not improve grade III-IV oropharyngeal mucositis (OM) in patients with hematological malignancies undergoing stem cell transplantation. Results of a

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001973.PUB3

Patient-controlled versus staff-controlled analgesia with pethidine after allogeneic bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001973.PUB3

Randomized phase II study of multiple dose levels of CCI-779, a novel mammalian target of rapamycin kinase inhibitor, in patients with advanced refractory renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001973.PUB3

Prolonged schedule of temozolomide (Temodal) plus liposomal doxorubicin (Caelyx) in advanced solid cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001973.PUB3

The effects of sucralfate suspension and diphenhydramine syrup plus kaolin-pectin on radiotherapy-induced mucositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001973.PUB3

Local antimicrobial therapy of oral mucositis in paediatric patients undergoing bone marrow transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001973.PUB3

Treatment of radiation- and chemotherapy-induced stomatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001973.PUB3

Effect of topical morphine for mucositis-associated pain following concomitant chemoradiotherapy for head and neck carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001973.PUB3

Differences among patients in opioid self-administration during bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001973.PUB3

Children's acceptance and tolerance of chlorhexidine and benzydamine oral rinses in the treatment of chemotherapy-induced oropharyngeal mucositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001973.PUB3

Effects of Na-sucrose octasulfate on skin and mucosa reactions during radiotherapy of head and neck cancers--a randomized prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001973.PUB3

A phase III, randomized, double-blind, placebo-controlled, study of iseganan for the reduction of stomatitis in patients receiving stomatotoxic chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001973.PUB3

Randomized controlled trial of pilocarpine hydrochloride for the moderation of oral mucositis during autologous blood stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001973.PUB3

Sucralfate for radiation mucositis: results of a double-blind randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001973.PUB3

Mucosa-adhesive water-soluble polymer film for treatment of acute radiation-induced oral mucositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001973.PUB3

Comparison of a patient-controlled analgesia system with continuous infusion for administration of diamorphine for mucositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001973.PUB3

Serious adverse effects of amifostine during radiotherapy in head and neck cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001973.PUB3

Palliation of radiation-related mucositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001973.PUB3

Tolerability and effects of two formulations of oral transmucosal fentanyl citrate (OTFC; ACTIQ) in patients with radiation-induced oral mucositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001973.PUB3

Local application of granulocyte-macrophage colony stimulating factor (GM-CSF) for the treatment of oral mucositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001973.PUB3

Palifermin: in myelotoxic therapy-induced oral mucositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001973.PUB3

Improving the quality of reporting of randomized controlled trials. The CONSORT statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001973.PUB3

Interventions for treating oral candidiasis for patients with cancer receiving treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001973.PUB3

Practical modalities for prevention of fungal infections in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001973.PUB3

Antifungal Prophylaxis during Neutropenia or Allogeneic Bone Marrow Transplantation: What is the State of the Art?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001973.PUB3

Antimicrobial therapy to prevent or treat oral mucositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001973.PUB3

Granulocyte macrophage-colony stimulating factor and oral mucositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001973.PUB3

Chemotherapy-induced oral mucositis. Prevention and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001973.PUB3

The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001973.PUB3

Prevention and treatment of chemotherapy- and radiotherapy-induced oral mucositis: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001973.PUB3

Oral management of patients following oncology treatment: literature review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001973.PUB3

A research review of the current treatments for radiation-induced oral mucositis in patients with head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001973.PUB3

Prophylaxis of oral mucositis in irradiated head-and-neck cancer patients: a proposed classification scheme of interventions and meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001973.PUB3

Treatment-induced mucositis: an old problem with new remedies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001973.PUB3

Mucositis incidence, severity and associated outcomes in patients with head and neck cancer receiving radiotherapy with or without chemotherapy: a systematic literature review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001973.PUB3

Cancer therapy and oral mucositis. An appraisal of drug prophylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001973.PUB3

Interventions for preventing oral mucositis for patients with cancer receiving treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001973.PUB3

Topical application of honey in the management of radiation mucositis: a preliminary study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001973.PUB3

7 January 2021

Vitamin E in the treatment of chemotherapy-induced mucositis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001973.PUB3

7 January 2021

Hypnosis or cognitive behavioral training for the reduction of pain and nausea during cancer treatment: a controlled clinical trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001973.PUB3

7 January 2021

Parenteral nutrition is not superior to replacement fluid therapy for the supportive treatment of chemotherapy induced oral mucositis in children

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001973.PUB3

7 January 2021

Double-blinded, placebo-controlled trial on intravenous l-alanyl-l-glutamine in the incidence of oral mucositis following chemoradiotherapy in patients with head-and-neck cancer

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001973.PUB3

7 January 2021

Patient-controlled analgesia for mucositis pain in children: a three-period crossover study comparing morphine and hydromorphone

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001973.PUB3

7 January 2021

A prospective, randomized study of cryotherapy during administration of high-dose melphalan to decrease the severity and duration of oral mucositis in patients with multiple myeloma undergoing autologous peripheral blood stem cell transplantation

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001973.PUB3

7 January 2021

Palifermin and chemotherapy-induced oral mucositis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001973.PUB3

7 January 2021

Defining clinically meaningful outcomes in the evaluation of new treatments for oral mucositis: oral mucositis patient provider advisory board

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001973.PUB3

7 January 2021

The effect of epidermal growth factor mouthwash on cytotoxic-induced oral ulceration. A phase I clinical trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001973.PUB3

7 January 2021

Antifungal prophylaxis during neutropenia and immunodeficiency

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001973.PUB3

7 January 2021

Comparative evaluation of benzydamine oral rinse in children with antineoplastic-induced stomatitis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001973.PUB3

7 January 2021

Phase III controlled evaluation of sucralfate to alleviate stomatitis in patients receiving fluorouracil-based chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001973.PUB3

7 January 2021

Therapeutic efficacy by recombinant human granulocyte/monocyte-colony stimulating factor on mucositis occurring in patients with oral and oropharynx tumors treated with curative radiotherapy: a multicenter open randomized phase III study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001973.PUB3

7 January 2021

A randomised, double-blind, parallel, placebo-controlled study to evaluate the efficacy of MF 5232 (Mucotrol), a concentrated oral gel wafer, in the treatment of oral mucositis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001973.PUB3

7 January 2021

Symptomatic acute mucositis can be minimized or prophylaxed by the combination of sucralfate and fluconazole

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001973.PUB3

7 January 2021